Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

Acne Infection

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

The Journal of dermatological treatment·2026

Same author

Benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the Heads Up trial.

The Journal of dermatological treatment·2026

Same author

Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis.

Dermatology and therapy·2026

Same author

Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States.

American journal of clinical dermatology·2026

Same author

Severity bands for atopic dermatitis measures: Analysis from adult dupilumab randomized clinical trials.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Same author

Dupilumab Treatment Up to 5 Years Shows No Clinically Meaningful Changes in Laboratory Parameters in Adults with Moderate-to-Severe Atopic Dermatitis.

Advances in therapy·2026

Same journal

Atopic Dermatitis: New Targets and Emerging Systemic Therapies.

American journal of clinical dermatology·2026

Same journal

Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions.

American journal of clinical dermatology·2026

Same journal

Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.

American journal of clinical dermatology·2026

Same journal

A Systematic Review of the Clinical Impact of GLP-1 Receptor Agonists in Hidradenitis Suppurativa.

American journal of clinical dermatology·2026

Same journal

What's New in Photoprotection?

American journal of clinical dermatology·2026

Same journal

Primary Cutaneous Cryptococcosis in Immunocompetent Patients: Recognition and Management.

American journal of clinical dermatology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 1, 2026

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Defining the Potential for Disease Modification in Atopic Dermatitis.

Eric L Simpson¹, Amy S Paller^2,3, Oscar Palomares⁴

¹Department of Dermatology, Oregon Health & Science University, 3303 SW Bond Ave, Portland, OR, 97239, USA. simpsone@ohsu.edu.

American Journal of Clinical Dermatology

|June 29, 2026

Summary

This summary is machine-generated.

Atopic dermatitis (AD) treatments are shifting from symptom relief to disease modification. Understanding AD

Related Experiment Videos

Last Updated: Jul 1, 2026

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Area of Science:

Dermatology
Immunology
Pathophysiology

Background:

Atopic dermatitis is a prevalent inflammatory skin condition with significant patient burden.
Current treatments primarily manage symptoms, not the disease course.
A clear definition of disease modification in AD is lacking.

Purpose of the Study:

To review the concept of disease modification in atopic dermatitis.
To explore dimensions of disease modification including pathophysiology, control, comorbidities, and biomarkers.
To emphasize the role of early intervention in altering AD progression.

Main Methods:

Literature review on disease modification in atopic dermatitis.
Analysis of underlying pathophysiology and disease control.
Examination of atopic and nonatopic comorbidities.
Discussion of subclinical biomarkers and early therapeutic strategies.

Main Results:

Emerging therapies may modify atopic dermatitis (AD) course, enabling remission and preventing comorbidities.
Disease modification in AD requires consensus on its definition and scope.
Identifying long-term effective therapies is crucial for reducing the global health burden of atopic diseases.

Conclusions:

Defining and achieving disease modification in atopic dermatitis is a key therapeutic goal.
A comprehensive approach considering pathophysiology, comorbidities, and biomarkers is needed.
Early interventions hold promise for altering the long-term trajectory of atopic dermatitis.